Skip to main content
José Luis Molinuevo

José Luis Molinuevo

Scientific Director Alzheimer's Prevention Program

Alzheimer's Prevention Program

Group leader of the Clinical, Biomarker and Risk factors Research Group 

Scientific activity:

  • Principal Investigation of Alfa Study, Alfa+, Alfa Genetics, Alfa Cognition and Barcelonaβeta Dementia Prevention Research Clinic
  • National lead of EPAD, a European consortium for the prevention of Alzheimer's dementia. 
  • Co-lead of TRIBEKA, an international consortium to generate an open access neuroimaging platform.
  • Co-lead of PENSA.
  • WP4 lead and principal investigator of the Prognostic and Natural History Study of AMYPAD
  • Principal Investigator at BBRC of several clinical trials (AB1601. Past: Generation I and Generation II). 
  • Membership in research networks, associations and international working groups: 
    • Member of the Neuroscience Steering Committee of the Biomarkers Consortium of the Foundation for the National Institutes of Health.
    • Member of the CSF Appropriate Use Criteria Workgroup.
    • Member of the National Institute on Aging and Alzheimer's Association (NIA-AA) Diagnostic Criteria.
    • Member of the European Alzheimer Disease Consortium.
    • Member of the Dementia Panel for the European Association of Neurology.
    • Member of the Alzheimer Biomarker Standarization Initiative.
    • Member of the  CIBER de Fragilidad y Envejecimiento Saludable.
  • He has served/serves as a consultant or at advisory boards for the following companies, or has given lectures: Roche Diagnostics, Roche, Genentech, Novartis, Lundbeck, Oryzon, Biogen, Lilly, Janssen, Green Valley, MSD, Eisai, Alector, BioCross, GE Healthcare, ProMIS Neurosciences, NovoNordisk, Cytox, Nutricia and Zambon. 
  • Scientific, technical and/or assessment committees: 
    • Co-Chair of the Alzheimer’s Disease International (ADI) Medical and Scientific Advisory Panel (MSAP) and member of the the MSAP Executive Committee.
    • Expert reviewer for the Spanish National Agency for Evaluation and Prospective (ANEP).
    • Editor Journal of Alzheimer's disease.
    • Editor Neurology Journal.
    • Associate editor and Editorial Board Member of Alzheimer’s Research & Therapy.
    • Editorial Board Member of Alzheimer's & Dementia: Translational Research & Clinical Interventions.
  • Associate professor at Pompeu Fabra University (Barcelona). 


  • 2010: Alzheimer's research award by the Spanish Society of Neurology. 
  • 2003: International Junior Investigator Award by the International College of Geriatric Psychoneuropharmacology.
  • 1998: Emili Letang Award (best residence and scientific research project), Hospital Clínic i Universitari de Barcelona.


  • 2001: PhD in Neurology. University of Barcelona, Spain. 
  • 1998: Residence in Neurology. University of Barcelona, Spain.
  • 1994: MD in Medicine. University of Valencia, Spain. 

Other positions

  • 2001-2016: Responsible of the Alzheimer's and Other Cognitive Units at Hospital Clínic de Barcelona and researcher at IDIBAPS. 
  • 1998-2001: Consultant Neurologist of the Movement Disease Unit at Hospital Clínic de Barcelona.
  • 1994-1998: Neurology resident at Hospital Clínic de Barcelona.